Phase II trial of therapeutic vaccine consisting of autologous dendritic cells loaded with autologous tumor cell antigens from self-renewing cancer cells in patients with newly diagnosed glioblastoma

被引：0
|
作者：
Bota, Daniela [1 ]
Piccioni, David [2 ]
LaRocca, Renato [3 ]
Duma, Christopher [4 ]
Aiken, Robert [5 ]
Kesari, Santosh [6 ]
Carrillo, Jose [6 ]
Taylor, Thomas [1 ]
Hsieh, Candace [7 ]
Nistor, Gabriel [7 ]
Dillman, Robert [7 ]
机构：
[1] Univ Calif Irvine, Orange, CA 92668 USA
[2] Univ Calif San Diego, San Diego, CA 92103 USA
[3] Norton Hosp, Louisville, KY USA
[4] Hoag Hosp, Newport Beach, CA USA
[5] Rutgers State Univ, New Brunswick, NJ USA
[6] John Wayne Canc Inst, Santa Monica, CA USA
[7] AiVita Biomed Inc, Irvine, CA USA
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2019年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
O22
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Correction to: First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma
    Linda M. Liau
    Keyoumars Ashkan
    David D. Tran
    Jian L. Campian
    John E. Trusheim
    Charles S. Cobbs
    Jason A. Heth
    Michael Salacz
    Sarah Taylor
    Stacy D. D’Andre
    Fabio M. Iwamoto
    Edward J. Dropcho
    Yaron A. Moshel
    Kevin A. Walter
    Clement P. Pillainayagam
    Robert Aiken
    Rekha Chaudhary
    Samuel A. Goldlust
    Daniela A. Bota
    Paul Duic
    Jai Grewal
    Heinrich Elinzano
    Steven A. Toms
    Kevin O. Lillehei
    Tom Mikkelsen
    Tobias Walbert
    Steven R. Abram
    Andrew J. Brenner
    Steven Brem
    Matthew G. Ewend
    Simon Khagi
    Jana Portnow
    Lyndon J. Kim
    William G. Loudon
    Reid C. Thompson
    David E. Avigan
    Karen L. Fink
    Francois J. Geoffroy
    Scott Lindhorst
    Jose Lutzky
    Andrew E. Sloan
    Gabriele Schackert
    Dietmar Krex
    Hans-Jorg Meisel
    Julian Wu
    Raphael P. Davis
    Christopher Duma
    Arnold B. Etame
    David Mathieu
    Santosh Kesari
    Journal of Translational Medicine, 16
  • [22] Vaccination with autologous dendritic cells loaded with autologous tumour homogenate in resected glioblastoma: A phase II study (CombiGVax)
    Ridolfi, L.
    Gurrieri, L.
    Riva, N.
    Fausti, V.
    Bongiovanni, A.
    Di Menna, G.
    De Rosa, F.
    Guidoboni, M.
    Mercatali, L.
    Bulgarelli, J.
    Foca, F.
    Tazzari, M.
    Calpona, S.
    Petrini, M.
    Granato, A.
    Pancisi, E.
    Dall'Agata, M.
    Valmorri, L.
    Tosatto, L.
    Ibrahim, T.
    ANNALS OF ONCOLOGY, 2021, 32 : S529 - S529
  • [23] PHASE II TRIAL OF AV-GBM-1 (AUTOLOGOUS DENDRITIC CELLS LOADED WITH TUMOR ASSOCIATED ANTIGENS) AS ADJUNCTIVE THERAPY FOLLOWING SURGERY PLUS CONCURRENT CHEMORADIATION IN NEWLY DIAGNOSED GBM PATIENTS
    Bota, Daniela
    Taylor, Thomas
    Picconi, David
    Duma, Christopher
    Aiken, Robert
    LaRocca, Renato
    Kong Xiao-Tang
    Fu, Beverly
    Alsharif, Mohamad
    Hsieh, Candace
    Nistor, Gabriel
    Dillman, Robert
    NEURO-ONCOLOGY, 2019, 21 : 7 - 7
  • [24] Phase I/IIa trial of autologous formalin-fixed tumor vaccine for newly diagnosed glioblastoma
    Muragaki, Y.
    Maruyama, T.
    Iseki, H.
    Tsuboi, K.
    Matsumura, A.
    Yamamoto, T.
    Matsutani, M.
    Karasawa, K.
    Nakazato, Y.
    Ohno, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [25] A phase II trial of autologous dendritic cell vaccination and radiochemotherapy following fluorescence-guided surgery in newly diagnosed glioblastoma patients
    Inoges, Susana
    Tejada, Sonia
    de Cerio, Ascension Lopez-Diaz
    Perez-Larraya, Jaime Gallego
    Espinos, Jaime
    Idoate, Miguel Angel
    Dominguez, Pablo Daniel
    de Eulate, Reyes Garcia
    Aristu, Javier
    Bendandi, Maurizio
    Pastor, Fernando
    Alonso, Marta
    Andreu, Enrique
    Cardoso, Felipe Prosper
    Valle, Ricardo Diez
    JOURNAL OF TRANSLATIONAL MEDICINE, 2017, 15
  • [26] A phase II trial of autologous dendritic cell vaccination and radiochemotherapy following fluorescence-guided surgery in newly diagnosed glioblastoma patients
    Susana Inogés
    Sonia Tejada
    Ascensión López-Díaz de Cerio
    Jaime Gállego Pérez-Larraya
    Jaime Espinós
    Miguel Angel Idoate
    Pablo Daniel Domínguez
    Reyes García de Eulate
    Javier Aristu
    Maurizio Bendandi
    Fernando Pastor
    Marta Alonso
    Enrique Andreu
    Felipe Prósper Cardoso
    Ricardo Díez Valle
    Journal of Translational Medicine, 15
  • [27] Randomized phase II trial of patient specific dendritic cell vaccines loaded with autologous tumor antigens versus autologous monocytes in patients with primary advanced ovarian cancer.
    Dillman, Robert O.
    Abaid, Lisa
    Hsieh, Candace
    Langford, Christopher
    Nistor, Gabriel I.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (08)
  • [28] Development of a therapeutic HIV vaccine comprised of autologous dendritic cells loaded with a mixture of lipopeptide HIV antigens
    Cobb, A. J.
    Mead, H.
    Montes, M.
    Ranganathan, R.
    Burkeholder, S.
    Perry-Finholt, J.
    Palucka, A. K.
    King, B.
    Sloan, L.
    Levy, Y.
    Roberts, L. K.
    Banchereau, J.
    RETROVIROLOGY, 2009, 6
  • [29] Results from the first step of a phase II study of vaccination with autologous dendritic cells loaded with autologous tumour homogenate in glioblastoma.
    Ridolfi, Laura
    Gurrieri, Lorena
    Riva, Nada
    Bulgarelli, Jenny
    De Rosa, Francesco
    Guidoboni, Massimo
    Fausti, Valentina
    Ranallo, Nicoletta
    Tazzari, Marcella
    Petrini, Massimiliano
    Granato, Anna Maria
    Pancisi, Elena
    Foca, Flavia
    Dall'Agata, Monia
    Amadori, Elena
    Cortesi, Pietro
    Gamboni, Alessandro
    Pasini, Giuseppe
    Ibrahim, Toni
    Tosatto, Luigino
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [30] T CELL RESPONSE DYNAMICS IN PHASE 3 GLIOBLASTOMA PATIENTS IMMUNIZED WITH AUTOLOGOUS DENDRITIC CELLS PULSED WITH AUTOLOGOUS TUMOR CELL LYSATE
    Bosch, Marnix
    Liau, Linda
    Ashkan, Keyoumars
    NEURO-ONCOLOGY, 2023, 25
12345